核酸分離精製市場：製品（キット、試薬、機器）、方法（カラム、磁気ビーズ）、タイプ（ゲノムDNA、プラスミドDNA、miRNA）、用途（創薬、診断）、エンドユーザー（製薬、バイオテクノロジー）別 - 2027年までの世界市場予測

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

核酸分離精製の世界市場は、2022年の63億米ドルから2027年には92億米ドルに達すると予測され、予測期間中のCAGRは7.9%となります。この市場の成長は、研究開発活動の増加、技術の進歩、自動化の進展が主な要因と... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年6月17日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	230	209	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

核酸分離精製の世界市場は、2022年の63億米ドルから2027年には92億米ドルに達すると予測され、予測期間中のCAGRは7.9%となります。この市場の成長は、研究開発活動の増加、技術の進歩、自動化の進展が主な要因となっています。新興国、規制および償還シナリオの改善、分子診断および個別化医療の採用拡大により、市場のプレイヤーに幅広い成長機会が提供されると期待されます。しかし、自動化機器の高コストが市場成長の妨げになることが予想されます。

世界のつながりが深まるにつれ、将来の伝染病の影響を軽減するために、連携と協力が必要とされています。将来の伝染病のリスクを軽減するために、世界中で研究が進められています。例えば、米国国立衛生研究所（National Institutes of Health）は、健康革新に年間400億米ドルを投資しており、COVID- 19の研究にさらに数十億ドルを費やすと予想されています。同様に、英国政府は今後 3 年間で研究開発費を増やし、2024-25 年までに 288.2 億米ドル（220 億英ポンド）に達することを決定している。中国やインドなどのアジアの国々も、ヘルスケアや医薬品分野への投資を増やしています。

"予測期間中、機器セグメントが最も高い成長率を示すだろう"
核酸分離精製市場は、製品ベースで、キット、試薬、機器に区分されます。2021年には、キットが市場で最大の製品セグメントとなりました。この市場の成長は、主要な市場プレーヤーが新しく高度なキットの開発および上市に継続的に注力していることに起因すると思われます。しかし、予測期間中は、機器セグメントが最も高い成長率を示すと予想されます。

"タイプ別では、2021年にプラスミドDNA分離・精製セグメントが核酸分離・精製市場で最大のシェアを占めています。"

世界の核酸分離精製市場は、タイプ別に、プラスミドDNA分離精製、トータルRNA分離精製、循環核酸分離精製、ゲノムDNA分離精製、メッセンジャーRNA分離精製、マイクロRNA分離精製、PCRクリーンアップ、その他の核酸分離精製タイプに区分されます。2021年の核酸分離精製市場では、プラスミドDNA分離セグメントが最大のシェアを占めています。この市場セグメントの大きなシェアは、PCR、配列決定、タンパク質の発現、遺伝子治療、トランスフェクションなどのさまざまな下流アプリケーションで精製プラスミドDNAが広く使用されていることに起因していると考えられます。

"アジア太平洋地域の市場は、予測期間(2020-2027)に最も高い成長率を目撃すると予測されます。"
2021年の核酸分離精製市場は、北米が最大のシェアを占めています。バイオテクノロジー企業や製薬企業における多額の研究開発費、バイオテクノロジー産業の規模の大きさ、技術の進歩、同地域の政府支援などが、北米の核酸分離精製市場の成長を促進する主な要因となっています。一方、アジア太平洋地域は、予測期間中に最も高い成長を記録すると予測されています。この大きなシェアは、同地域におけるゲノムプロジェクトの増加や、製薬・バイオテクノロジー企業による研究開発投資の増加などの要因によるものです。

本レポートで参照した主な参加企業の内訳は以下のとおりです。
- 企業タイプ別（供給側）:供給側：Tier1(29%)、Tier2(37%)、Tier3(34%)
- カテゴリー別（需要側）。需要側：製薬・バイオテクノロジー企業（38%）、病院・診断センター（30%）、学術・政府研究機関（22%）、その他エンドユーザー（10%）。
- 役職別Cレベル(37%), ディレクターレベル(23%), マネージャー(40%)
- 地域別北米(37%), 欧州(30%), アジア太平洋(21%), アジア太平洋地域(12%)

QIAGEN N.V.（オランダ）、Thermo Fisher Scientific（米国）、F. Hoffmann-La Roche Ltd.（スイス）の3社です。(スイス)が、世界の核酸分離精製市場の主要プレーヤーです。その他の注目すべきプレーヤーとしては、Promega Corporation（米国）、Agilent Technologies（米国）、Bio-Rad Laboratories（米国）、Danaher Corporation（米国）、GEHealthcare（米国）、Illumina, Inc.（米国）、Merck KGG（米国）が挙げられます。(米国）、Merck KGaA（ドイツ）、タカラバイオ（日本）、Zymo Research（米国）、New England Biolabs（米国）、Norgen Biotek Corp（カナダ）、Omega Bio-tek （米国）、Genaxxon Bioscience GmbH（ドイツ）、3B BlackBio Biotech India Limited（インド）、Invitek Molecular（ドイツ）、BioVision （米国）および Analytik Jena AG（ドイツ）などがあります。
調査対象範囲
当レポートでは、核酸分離精製市場を分析し、製品、方法、タイプ、アプリケーション、エンドユーザー、地域などの様々なセグメントに基づいて、同市場の市場規模および今後の成長可能性を推定することを目的としています。また、同市場の主要企業の競合分析、企業プロファイル、製品・サービス内容、最近の開発状況、主要な市場戦略も掲載しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業が市場の脈拍を測るのに役立ち、ひいてはより大きなシェアを獲得するのに役立つでしょう。本レポートを購入された企業は、以下の5つの戦略を1つ、または組み合わせて使用することができます。

本レポートでは、以下のポイントについて解説しています。
- 市場浸透。核酸分離精製市場のトッププレイヤーの製品ポートフォリオに関する包括的な情報。製品、タイプ、アプリケーション、エンドユーザー、地域に基づいて市場を分析しています。
- 製品開発/イノベーション。核酸分離精製市場における今後の技術、研究開発活動、製品の上市に関する詳細な洞察。
- 市場開発。有利な新興市場に関する包括的な情報。本レポートでは、様々なタイプの核酸分離・精製ソリューションの市場を地域ごとに分析しています。
- 市場の多様化。核酸分離精製市場の製品、未開拓地域、最近の開発、投資に関する詳細な情報を提供します。
- 競争力の評価。核酸分離精製市場の主要企業の市場シェア、戦略、製品、流通網、製造能力に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 31
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS 31
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 35
FIGURE 2 PRIMARY SOURCES 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Breakdown of primary sources 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION,
AND REGION 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC (2021) 37
2.3 MARKET GROWTH RATE PROJECTIONS 39
FIGURE 6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTION 39
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 7 DATA TRIANGULATION METHODOLOGY 40
2.5 MARKET SHARE ESTIMATION 41
2.6 ASSUMPTIONS FOR THE STUDY 41
2.7 LIMITATIONS FOR RESEARCH 41
3 EXECUTIVE SUMMARY 42
FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 42
FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2022 VS. 2027 (USD MILLION) 43
FIGURE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 44
FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 45
FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 46
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 47
4 PREMIUM INSIGHTS 48
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW 48
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH 48
4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT (2021) 49
FIGURE 15 KITS TO DOMINATE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2021 49
4.3 GEOGRAPHICAL SNAPSHOT OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 50
FIGURE 16 JAPAN TO WITNESS HIGHEST MARKET GROWTH RATE FROM 2022 TO 2027 50
4.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 51
FIGURE 17 NORTH AMERICA TO DOMINATE MARKET IN 2027 51
4.5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEVELOPED VS. DEVELOPING MARKETS 52
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE
IN FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 MARKET DYNAMICS 53
FIGURE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 53
5.1.1 DRIVERS 54
5.1.1.1 Increasing R&D activities 54
5.1.1.2 Technological advancements and increasing automation 55
5.1.2 RESTRAINTS 55
5.1.2.1 High cost of automated instruments 55
5.1.3 OPPORTUNITIES 55
5.1.3.1 High scope of growth in emerging economies 55
5.1.3.2 Improving regulatory and reimbursement scenario 56
5.1.3.3 Molecular diagnostics and personalized medicine 56
5.1.4 TRENDS 57
5.1.4.1 Increase in government funding 57
5.2 COVID-19 IMPACT ON THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 57
5.3 PORTER’S FIVE FORCES ANALYSIS 58
TABLE 1 PORTER’S FIVE FORCES ANALYSIS 58
5.3.1 THREAT FROM NEW ENTRANTS 59
5.3.2 THREAT FROM SUBSTITUTES 59
5.3.3 BARGAINING POWER OF SUPPLIERS 59
5.3.4 BARGAINING POWER OF BUYERS 59
5.3.5 DEGREE OF COMPETITION 59
5.4 TECHNOLOGY ANALYSIS 59
5.5 SUPPLY CHAIN ANALYSIS 61
FIGURE 20 SUPPLY CHAIN ANALYSIS: NUCLEIC ACID ISOLATION AND
PURIFICATION MARKET 61
6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 62
6.1 INTRODUCTION 63
TABLE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2019–2021 (USD MILLION) 63
TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2022–2027 (USD MILLION) 64
6.2 PLASMID DNA ISOLATION AND PURIFICATION 64
6.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 64
TABLE 4 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 65
TABLE 5 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 66
6.3 TOTAL RNA ISOLATION AND PURIFICATION 66
6.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO
REGISTER STEADY GROWTH 66
TABLE 6 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 67
TABLE 7 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 67
6.4 GENOMIC DNA ISOLATION AND PURIFICATION 68
6.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS 68
TABLE 8 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 68
TABLE 9 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 69
6.5 MESSENGER RNA ISOLATION AND PURIFICATION 69
6.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS 69
TABLE 10 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION) 70
TABLE 11 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION) 70
6.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 71
6.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 71
TABLE 12 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY REGION, 2019–2021 (USD MILLION) 71
TABLE 13 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY REGION, 2022–2027 (USD MILLION) 72
6.7 MICRORNA ISOLATION AND PURIFICATION 72
6.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF
RNA MOLECULES FROM SAMPLES 72
TABLE 14 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 73
TABLE 15 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 73
6.8 PCR CLEANUP 74
6.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD 74
TABLE 16 PCR CLEANUP MARKET, BY REGION, 2019–2021 (USD MILLION) 74
TABLE 17 PCR CLEANUP MARKET, BY REGION, 2022–2027 (USD MILLION) 74
6.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES 75
TABLE 18 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,
BY REGION, 2019–2021 (USD MILLION) 75
TABLE 19 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,
BY REGION, 2022–2027 (USD MILLION) 76
7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 77
7.1 INTRODUCTION 78
TABLE 20 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2019–2021 (USD MILLION) 78
TABLE 21 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2022–2027 (USD MILLION) 78
7.2 COLUMN-BASED ISOLATION AND PURIFICATION 79
7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION IS LARGEST SEGMENT
OF MARKET 79
TABLE 22 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION) 79
TABLE 23 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION) 80
7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 80
7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT
TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 80
TABLE 24 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,
BY REGION, 2019–2021 (USD MILLION) 81
TABLE 25 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,
BY REGION, 2022–2027 (USD MILLION) 81
7.4 REAGENT-BASED ISOLATION AND PURIFICATION 81
7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH BETWEEN 2022 AND 2027 81
TABLE 26 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION) 82
TABLE 27 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION) 82
7.5 OTHER ISOLATION AND PURIFICATION METHODS 83
TABLE 28 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2019–2025 (USD MILLION) 83
TABLE 29 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2022–2027 (USD MILLION) 83
8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 84
8.1 INTRODUCTION 85
TABLE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2019–2021 (USD MILLION) 85
TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2022–2027 (USD MILLION) 85
8.2 KITS 86
8.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2021 86
TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2019–2021 (USD MILLION) 86
TABLE 33 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2022–2027 (USD MILLION) 87
8.3 REAGENTS 87
8.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING
THE FORECAST PERIOD 87
TABLE 34 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,
BY REGION, 2019–2021 (USD MILLION) 88
TABLE 35 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,
BY REGION, 2022–2027 (USD MILLION) 88
8.4 INSTRUMENTS 89
8.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS 89
TABLE 36 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,
BY REGION, 2019–2021 (USD MILLION) 89
TABLE 37 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,
BY REGION, 2022–2027 (USD MILLION) 90
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 91
9.1 INTRODUCTION 92
TABLE 38 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019–2021 (USD MILLION) 92
TABLE 39 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 92
9.2 DIAGNOSTICS 93
9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET 93
TABLE 40 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2021 (USD MILLION) 93
TABLE 41 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2027 (USD MILLION) 94

9.3 DRUG DISCOVERY & DEVELOPMENT 94
9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS
THERAPEUTIC AREAS 94
TABLE 42 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2021 (USD MILLION) 95
TABLE 43 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2027 (USD MILLION) 95
9.4 PERSONALIZED MEDICINE 96
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE SEGMENT GROWTH 96
TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2019–2021 (USD MILLION) 96
TABLE 45 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2027 (USD MILLION) 97
9.5 AGRICULTURE & ANIMAL RESEARCH 97
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH 97
TABLE 46 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2019–2021 (USD MILLION) 98
TABLE 47 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2027 (USD MILLION) 98
9.6 OTHER APPLICATIONS 99
TABLE 48 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2021 (USD MILLION) 99
TABLE 49 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2027 (USD MILLION) 100
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 101
10.1 INTRODUCTION 102
TABLE 50 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2019–2021 (USD MILLION) 102
TABLE 51 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2022–2027 (USD MILLION) 102
10.2 HOSPITALS & DIAGNOSTIC CENTERS 103
10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH 103
TABLE 52 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2019–2021 (USD MILLION) 104
TABLE 53 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2027 (USD MILLION) 104
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 104
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS 104
TABLE 54 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2021 (USD MILLION) 105
TABLE 55 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022–2027 (USD MILLION) 106
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 106
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH 106
TABLE 56 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2019–2021 (USD MILLION) 107
TABLE 57 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2022–2027 (USD MILLION) 107
10.5 CONTRACT RESEARCH ORGANIZATIONS 107
10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING FORECAST PERIOD 107
TABLE 58 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2021 (USD MILLION) 108
TABLE 59 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2027 (USD MILLION) 108
10.6 OTHER END USERS 108
TABLE 60 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2019–2021 (USD MILLION) 109
TABLE 61 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR
OTHER END USERS, BY REGION, 2022–2027 (USD MILLION) 109
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 110
11.1 INTRODUCTION 111
TABLE 62 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION,
2020–2027 (USD MILLION) 111
11.2 NORTH AMERICA 111
FIGURE 21 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 112
TABLE 63 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 64 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 65 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 113
TABLE 66 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 67 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 114
TABLE 68 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
11.2.1 US 115
11.2.1.1 Government and private funding to support market growth 115
TABLE 69 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116
TABLE 70 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 116
TABLE 71 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2020–2027 (USD MILLION) 117
TABLE 72 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
TABLE 73 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 118
11.2.2 CANADA 118
11.2.2.1 Growing investments in genomics to boost market demand 118
TABLE 74 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 75 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 119
TABLE 76 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 77 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 120
TABLE 78 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 121
11.3 EUROPE 121
TABLE 79 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 80 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 81 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 122
TABLE 82 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 83 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 84 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 124
11.3.1 GERMANY 124
11.3.1.1 Germany to dominate market in Europe 124
TABLE 85 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027 125
TABLE 86 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 87 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 126
TABLE 88 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 89 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 127
TABLE 90 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 127
11.3.2 UK 127
11.3.2.1 Government support for research through investments, funds, and grants to support market growth 127
TABLE 91 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 92 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 128
TABLE 93 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2020–2027 (USD MILLION) 129
TABLE 94 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 95 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 130
11.3.3 FRANCE 130
11.3.3.1 High cancer burden to drive market growth 130
TABLE 96 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 97 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 131
TABLE 98 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 99 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 100 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 133
11.3.4 REST OF EUROPE 133
TABLE 101 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 134
TABLE 102 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 134
11.4 ASIA PACIFIC 135
FIGURE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 135
TABLE 103 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 104 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 136
TABLE 105 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 136
TABLE 106 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 107 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 137
TABLE 108 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 138
11.4.1 CHINA 138
11.4.1.1 China is expected to register the highest growth in the nucleic acid isolation and purification market in the APAC 138
TABLE 109 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 139
TABLE 110 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 139
TABLE 111 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 112 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 113 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 141
11.4.2 JAPAN 141
11.4.2.1 Various conferences & workshops are organized to explore various NAIP applications; a key factor driving market growth 141
TABLE 114 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142
TABLE 115 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 142
TABLE 116 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 117 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 118 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 144
11.4.3 INDIA 144
11.4.3.1 Focused initiatives in the pharmaceutical & biotechnology industries to drive the market growth for NAIP in India 144
TABLE 119 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 144
TABLE 120 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 145
TABLE 121 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 122 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 123 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 146
11.4.4 REST OF ASIA PACIFIC (ROAPAC) 147
TABLE 124 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 147
TABLE 125 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 148
TABLE 126 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 127 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 149
TABLE 128 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 149
11.5 REST OF THE WORLD 150
TABLE 129 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 130 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 131 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 150
TABLE 132 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 133 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 151
TABLE 134 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 152
11.5.1 LATIN AMERICA 152
11.5.1.1 Increasing cancer cases to drive the demand for cancer diagnostic tests and, in turn, drive market growth for NAIP 152
TABLE 135 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 153
TABLE 136 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 153
TABLE 137 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 138 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 139 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 155
11.5.2 MIDDLE EAST & AFRICA 155
11.5.2.1 Lack of research infrastructure to restrict the growth of the NAIP market in this region 155
TABLE 140 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 156
TABLE 141 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 156
TABLE 142 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 143 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 157
TABLE 144 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 158
TABLE 145 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 146 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 159
TABLE 147 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 159
12 COMPETITIVE LANDSCAPE 160
12.1 OVERVIEW 160
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 160
FIGURE 23 KEY DEVELOPMENTS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019-2022 160
12.3 MARKET SHARE ANALYSIS 161
FIGURE 24 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE,
BY KEY PLAYER, 2021 161
TABLE 148 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET:
DEGREE OF COMPETITION 161
12.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 162
FIGURE 25 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019–2021 162
12.5 COMPANY EVALUATION QUADRANT 163
12.5.1 STARS 163
12.5.2 EMERGING LEADERS 163
12.5.3 PERVASIVE PLAYERS 163
12.5.4 PARTICIPANTS 163
FIGURE 26 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT, 2021 164
12.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 165
12.6.1 PROGRESSIVE COMPANIES 165
12.6.2 STARTING BLOCKS 165
12.6.3 RESPONSIVE COMPANIES 165
12.6.4 DYNAMIC COMPANIES 165
FIGURE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 166
12.7 COMPANY FOOTPRINT ANALYSIS 167
12.7.1 COMPANY PRODUCT FOOTPRINT 167
TABLE 149 COMPANY PRODUCT FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021) 167
12.8 COMPANY REGIONAL FOOTPRINT 168
TABLE 150 COMPANY REGIONAL FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021) 168
12.9 COMPETITIVE SCENARIO 169
TABLE 151 PRODUCT LAUNCHES 169
TABLE 152 DEALS 169
TABLE 153 OTHER DEVELOPMENTS 170
13 COMPANY PROFILES 171
13.1 MAJOR PLAYERS 171
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 THERMO FISHER SCIENTIFIC, INC. 171
TABLE 154 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 171
FIGURE 28 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 172
13.1.2 MERCK KGAA 176
TABLE 155 MERCK KGAA: BUSINESS OVERVIEW 176
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2021) 177
13.1.3 QIAGEN 182
TABLE 156 QIAGEN: BUSINESS OVERVIEW 182
FIGURE 30 QIAGEN: COMPANY SNAPSHOT (2021) 183
13.1.4 F. HOFFMANN-LA ROCHE AG 186
TABLE 157 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW 186
FIGURE 31 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021) 187
13.1.5 GENERAL ELECTRIC COMPANY 191
TABLE 158 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW 191
FIGURE 32 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021) 192
13.1.6 PROMEGA CORPORATION 194
TABLE 159 PROMEGA CORPORATION: BUSINESS OVERVIEW 194
13.1.7 AGILENT TECHNOLOGIES, INC. 197
TABLE 160 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 197
FIGURE 33 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 198
13.1.8 DANAHER CORPORATION 201
TABLE 161 DANAHER CORPORATION: BUSINESS OVERVIEW 201
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 202
13.1.9 BIO-RAD LABORATORIES, INC. 205
TABLE 162 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 205
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 206
13.1.10 ILLUMINA, INC. 208
TABLE 163 ILLUMINA, INC.: BUSINESS OVERVIEW 208
FIGURE 36 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 209
13.1.11 TAKARA BIO, INC. 211
TABLE 164 TAKARA BIO, INC.: BUSINESS OVERVIEW 211
13.1.12 NEW ENGLAND BIOLABS 215
TABLE 165 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW 215
13.1.13 OMEGA BIO-TEK, INC. 217
TABLE 166 OMEGA BIO-TEK, INC.: BUSINESS OVERVIEW 217
13.1.14 NORGEN BIOTEK 219
TABLE 167 NORGEN BIOTEK: BUSINESS OVERVIEW 219
13.1.15 ZYMO RESEARCH 221
TABLE 168 ZYMO RESEARCH: BUSINESS OVERVIEW 221
13.2 OTHER COMPANIES 224
13.2.1 GENAXXON BIOSCIENCE GMBH 224
TABLE 169 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW 224
13.2.2 3D BLACKBIO BIOTECH INDIA LTD. 225
TABLE 170 3D BLACKBIO BIOTECH INDIA LTD.: COMPANY OVERVIEW 225
13.2.3 INVITEK MOLECULAR GMBH 226
TABLE 171 INVITEK MOLECULAR GMBH: COMPANY OVERVIEW 226
13.2.4 BIOVISION 228
TABLE 172 BIOVISION: COMPANY OVERVIEW 228
13.2.5 ANALYTIK JENA AG 229
TABLE 173 ANALYTIK JENA AG: COMPANY OVERVIEW 229
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 230
14.1 DISCUSSION GUIDE 230
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
14.3 AVAILABLE CUSTOMIZATIONS 235
14.4 RELATED REPORTS 236
14.5 AUTHOR DETAILS 237

ページTOPに戻る

Table of Contents

Summary

The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market.

As the world becomes more connected, collaboration and cooperation are needed to reduce the impact of future epidemics. To reduce the risk of future epidemics, increasing research is being conducted across the globe. For instance, the National Institutes of Health (US) invests USD 40 billion annually in health innovation and is expected to spend billions more on COVID- 19 research. Similarly, the UK government has decided to increase its R&D spending over the next three years to reach USD 28.82 billion (GBP 22 billion) by 2024–25. Countries in Asia, such as China and India, have also increased investments in their healthcare and pharmaceutical sectors.

“The instruments segment will grow at the highest rate during the forecast period.”
On the basis ofproduct, the nucleic acid isolation and purification market is segmented intokits, reagents, and instruments. In 2021, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.

“By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.”

On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation andpurification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.

“The market in the Asia Pacificis projected to witness the highest growth rate during the forecast period (2020–2027).”
North America accounted for the largest share of the nucleic acid isolation and purification market in 2021. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacificis projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1(29%), Tier 2(37%), and Tier 3(34%)
• By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals& Diagnostic Centers (30%), and Academic &Government Research Institutes (22%), and Other End Users (10%)
• By Designation: C-level(37%), Director-level(23%), and Managers(40%)
• By Region: North America(37%), Europe(30%), Asia Pacific(21%), and the RoW(12%)

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GEHealthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
Research Coverage:
The report analyzes the nucleic acid isolation and purification market and aims at estimating themarket size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthemgarner a greater share. Firms purchasing the report could use one, or a combination of the belowmentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutionsacross regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（dna）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（dna）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?